» Articles » PMID: 23474986

CLP1 Links TRNA Metabolism to Progressive Motor-neuron Loss

Abstract

CLP1 was the first mammalian RNA kinase to be identified. However, determining its in vivo function has been elusive. Here we generated kinase-dead Clp1 (Clp1(K/K)) mice that show a progressive loss of spinal motor neurons associated with axonal degeneration in the peripheral nerves and denervation of neuromuscular junctions, resulting in impaired motor function, muscle weakness, paralysis and fatal respiratory failure. Transgenic rescue experiments show that CLP1 functions in motor neurons. Mechanistically, loss of CLP1 activity results in accumulation of a novel set of small RNA fragments, derived from aberrant processing of tyrosine pre-transfer RNA. These tRNA fragments sensitize cells to oxidative-stress-induced p53 (also known as TRP53) activation and p53-dependent cell death. Genetic inactivation of p53 rescues Clp1(K/K) mice from the motor neuron loss, muscle denervation and respiratory failure. Our experiments uncover a mechanistic link between tRNA processing, formation of a new RNA species and progressive loss of lower motor neurons regulated by p53.

Citing Articles

Mechanistic basis for PYROXD1-mediated protection of the human tRNA ligase complex against oxidative inactivation.

Loeff L, Kroupova A, Asanovic I, Boneberg F, Pfleiderer M, Riermeier L Nat Struct Mol Biol. 2025; .

PMID: 40069351 DOI: 10.1038/s41594-025-01516-6.


tRF-5028c disrupts trophoblast function in recurrent spontaneous abortion by inhibiting CRKL-mediated Rap1 signaling pathway.

Huang J, Wang J, Wang S, Xiong X, Jiang R, Xiong C Cell Mol Biol Lett. 2025; 30(1):28.

PMID: 40045194 PMC: 11881442. DOI: 10.1186/s11658-025-00706-w.


Exploring the Potential of tsRNA as Biomarkers for Diagnosis and Treatment of Neurogenetic Disorders.

Zhao S, Wang Y, Zhou L, Li Z, Weng Q Mol Neurobiol. 2025; .

PMID: 40009263 DOI: 10.1007/s12035-025-04760-5.


tsRNA-5006c regulates hippocampal neurons ferroptosis to ameliorate perioperative neurocognitive disorders in aged male mice.

Zhou C, Lian F, Li H, Deng F 3 Biotech. 2024; 15(1):16.

PMID: 39711920 PMC: 11655729. DOI: 10.1007/s13205-024-04176-3.


tsRNAs: A Prospective, Effective Therapeutic Intervention for Neurodegenerative Diseases.

Li T, Zhen H, Wu W, Yang F, Cao Z CNS Neurosci Ther. 2024; 30(12):e70177.

PMID: 39690867 PMC: 11652788. DOI: 10.1111/cns.70177.


References
1.
Jain R, Shuman S . Characterization of a thermostable archaeal polynucleotide kinase homologous to human Clp1. RNA. 2009; 15(5):923-31. PMC: 2673061. DOI: 10.1261/rna.1492809. View

2.
Dumaz N, Meek D . Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 1999; 18(24):7002-10. PMC: 1171763. DOI: 10.1093/emboj/18.24.7002. View

3.
Chao C, Hergenhahn M, Kaeser M, Wu Z, Saito S, Iggo R . Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses. J Biol Chem. 2003; 278(42):41028-33. DOI: 10.1074/jbc.M306938200. View

4.
Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S . Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell. 2001; 105(5):587-97. DOI: 10.1016/s0092-8674(01)00363-4. View

5.
Hurto R . Unexpected functions of tRNA and tRNA processing enzymes. Adv Exp Med Biol. 2011; 722:137-55. DOI: 10.1007/978-1-4614-0332-6_9. View